We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,406
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LBBBR
13351
DELISTED
Lakeshore Acquisition II Corp. Rights
LBBBR
$4.86K ﹤0.01%
+24,277
New +$4.46K
ADCT icon
13352
PUT
ADC Therapeutics
ADCT
$128M
$4.84K ﹤0.01%
5,400
-5,700
-51% -$7.58K
WIT icon
13353
PUT
Wipro
WIT
$19.2B
$4.84K ﹤0.01%
2,000
-13,000
-87% -$32.4K
PLSE icon
13354
PUT
Pulse Biosciences
PLSE
$3.18B
$4.84K ﹤0.01%
+1,200
New +$7.46K
TPHS
13355
DELISTED
Trinity Place Holdings Inc.com
TPHS
$4.83K ﹤0.01%
13,225
-7,063
-35% -$3.29K
NKTR icon
13356
CALL
Nektar Therapeutics
NKTR
$2.47B
$4.82K ﹤0.01%
540
-1,200
-69% -$11.6K
VMBS icon
13357
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.6B
$4.82K ﹤0.01%
110
-5,179
-98% -$233K
WRAP icon
13358
PUT
Wrap Technologies
WRAP
$105M
$4.8K ﹤0.01%
3,200
+300
+10% +$504
QVCGA
13359
CALL
DELISTED
QVC Group Inc Series A
QVCGA
$4.79K ﹤0.01%
158
-82
-34% -$3.46K
SCHO icon
13360
PUT
Schwab Short-Term US Treasury ETF
SCHO
$13B
$4.79K ﹤0.01%
200
-5,600
-97% -$134K
ICMB icon
13361
PUT
Investcorp Credit Management BDC
ICMB
$12.1M
$4.79K ﹤0.01%
1,200
-1,000
-45% -$3.95K
SCHE icon
13362
PUT
Schwab Emerging Markets Equity ETF
SCHE
$12.8B
$4.79K ﹤0.01%
+200
New +$4.95K
CLLS
13363
CALL
Cellectis
CLLS
$307M
$4.74K ﹤0.01%
3,000
-2,300
-43% -$4.49K
STOK icon
13364
CALL
Stoke Therapeutics
STOK
$2.02B
$4.73K ﹤0.01%
1,200
-9,200
-88% -$60.5K
CPSH icon
13365
CALL
CPS Technologies
CPSH
$83.6M
$4.73K ﹤0.01%
1,700
-30,500
-95% -$85.9K
AAPU icon
13366
PUT
Direxion Daily AAPL Bull 2X ETF
AAPU
$188M
$4.71K ﹤0.01%
+200
New +$5.31K
VMD icon
13367
CALL
Viemed Healthcare
VMD
$350M
$4.71K ﹤0.01%
700
-8,300
-92% -$68K
CMRX
13368
CALL
DELISTED
Chimerix, Inc.
CMRX
$4.7K ﹤0.01%
4,900
-8,000
-62% -$8.71K
IMTE icon
13369
Integrated Media Technology
IMTE
$1.8M
$4.7K ﹤0.01%
+2,414
New +$6.62K
AFMD
13370
CALL
DELISTED
Affimed
AFMD
$4.68K ﹤0.01%
980
-330
-25% -$1.82K
SHO icon
13371
PUT
Sunstone Hotel Investors
SHO
$2.03B
$4.67K ﹤0.01%
500
+400
+400% +$3.78K
LLAP
13372
DELISTED
Terran Orbital Corporation
LLAP
$4.67K ﹤0.01%
+5,607
New +$7.43K
IDN icon
13373
CALL
Intellicheck
IDN
$56.9M
$4.66K ﹤0.01%
2,100
-7,000
-77% -$17.6K
VRCA icon
13374
CALL
Verrica Pharmaceuticals
VRCA
$85.4M
$4.66K ﹤0.01%
120
-1,320
-92% -$67.1K
ADN
13375
PUT
DELISTED
Advent Technologies
ADN
$4.66K ﹤0.01%
397
+47
+13% +$925
533 534
535
536 537

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.